Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT02184923
Other study ID # verticality_percept_stroke_zrh
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date August 2014
Est. completion date December 31, 2020

Study information

Verified date December 2019
Source University of Zurich
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The long-term goal of this research is to advance our knowledge of how information from the labyrinth is brought to perception and how adaptation to vestibular imbalance influences spatial orientation. In healthy human subjects verticality perception is accurate while upright.The strategy of this research is to quantify changes in verticality perception after unilateral lesions along the central graviceptive pathways and to assess the frequency and pattern of abnormal verticality perception in patients with acute stroke (ischemic or hemorrhagic). Our underlying hypothesis is that screening for erroneous verticality perception by use of a mobile device assessing the subjective visual vertical (SVV) during the acute phase (i.e., within 24-48 hours after symptom onset) reliably identifies those patients with defects. Early detection of deficits in verticality perception may help to initiate balance physiotherapy early.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 130
Est. completion date December 31, 2020
Est. primary completion date December 31, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria:

1. ages 18-90 years

2. informed consent

3. for group 1: acute (i.e. symptom onset <3 days ago) lateralized ischemia or hemorrhage as confirmed by clinical examination and / or brain imaging (CT or MRI).

4. absence of exclusion criteria

Exclusion Criteria:

1. history of a peripheral-vestibular deficit

2. disturbed consciousness

3. severe sensory or motor aphasia

4. visual field deficits

5. other neurological or systemic disorder which can cause dementia or cognitive dysfunction

6. intake of antidepressants, sedatives, or neuroleptics

Study Design


Related Conditions & MeSH terms


Intervention

Other:
presentation of visual vertical


Locations

Country Name City State
Switzerland University Hospital Zurich Zurich ZH

Sponsors (1)

Lead Sponsor Collaborator
University of Zurich

Country where clinical trial is conducted

Switzerland, 

References & Publications (1)

Zwergal A, Rettinger N, Frenzel C, Dieterich M, Brandt T, Strupp M. A bucket of static vestibular function. Neurology. 2009 May 12;72(19):1689-92. doi: 10.1212/WNL.0b013e3181a55ecf. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Accuracy of verticality perception during the measurement period (10 minutes)
Secondary Test-re-test reliability of verticality perception from session 1 (day 0) to session 2 (day 1)